Wolverine Asset Management LLC Ascendis Pharma A/S Put Options Transaction History

Wolverine Asset Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 07, 2023	BUY	$69.96 - $97.84 $48,971 - $68,488	700 Added 70.0%	1,700 $151,000
Q1 2023 May 08, 2023	BUY	$104.9 - $126.78 $52,450 - $63,390	500 Added 100.0%	1,000 $107,000
Q4 2022 Feb 01, 2023	SELL	$99.42 - $131.97 $4.05 Million - $5.37 Million	-40,700 Reduced 98.79%	500 $61,000
Q3 2022 Nov 10, 2022	BUY	$84.03 - $110.23 $42,015 - $55,115	500 Added 1.23%	41,200 $4.25 Million
Q1 2022 May 04, 2022	BUY	$102.18 - $135.75 $4.16 Million - $5.53 Million	40,700 New	40,700 $4.78 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.